Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea

International Journal of Epidemiology

Volumn 29, Issue 3, 2000, Pages 579-586

  Stirnadel, Heide A ^a   Al Yaman, F ^b   Genton, B ^a,b   Alpers, M P ^b   Smith, T A ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

Author keywords

Children; IgG; Malaria; Papua New Guinea; Variance component analysis

Indexed keywords

IMMUNOGLOBULIN G; MALARIA VACCINE; MEMBRANE ANTIGEN; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2;

CHILD HEALTH; DISEASE TREATMENT; IMMUNIZATION; MALARIA;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CHILD; ENDEMIC DISEASE; ENVIRONMENTAL FACTOR; GENETIC HETEROGENEITY; GENETIC REGULATION; GENETIC VARIABILITY; HEREDITY; HUMAN; IMMUNE RESPONSE; INFANT; MALARIA; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; VACCINE PRODUCTION; VARIANCE;

PAPUA NEW GUINEA;

EID: 0033937369     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/intjepid/29.3.579     Document Type: Article

References (53)

1. McGregor IA, Wilson RJM. Specific immunity: acquired in man. In: Wernsdorfer WH, McGregor IA (eds). Malaria - Principles and Practice of Malariology. 1988, pp.559-619.
2. Cohen S, McGregor IA, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 1961;192:733-37.
3. McGregor IA, Carrington S, Cohen S. Treatment of East African P. falciparum malaria with West African gamma-globulin. Trans R Soc Trop Med Hyg 1963;57:170-75.
4. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990;172:1633-41.
5. Sabchareon A, Burnouf T, Ouattara D et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 1991;45:297-308.
6. Al-Yaman F, Genton B, Falk M et al. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 1995;52: 66-71.
7. Beck HP, Felger I, Genton B et al. Humoral and cell-mediated immunity to Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria. Infect Immun 1995;63:596-600.
8. Al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP. Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area. Parasite Immunol 1997;19:249-54.
9. Riley EM, Allen SJ, Wheeler JG et al. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 1992;14:321-37.
10. Tolle R, Fruh K, Doumbo O et al. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect Immun 1993;61:40-47.
11. Al-Yaman F, Genton B, Kramer KJ et al. Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea. Trans R Soc Trop Med Hyg 1995;89:555-59.
12. Al-Yaman F, Genton B, Kramer KJ et al. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am J Trop Med Hyg 1996;54:443-48.
13. Al-Yaman F, Genton B, Anders RF et al. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 1994;51:593-602.
14. Al-Yaman F, Genton B, Anders R et al. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol 1995;17:493-501.
15. Al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status. Parasite Immunol 1997;19:207-14.
16. Beck HP, Felger I, Kabintik S et al. Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea. Am J Trop Med Hyg 1994;51:356-64.
17. Hviid L. Peripheral T-cell non-responiveness in individuals exposed to Plasmodium falciparum malaria. 1995, pp.5-46. (Thesis.)
18. Riley EM. The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens. Parasitol 1996;112:39-51.
19. Allansmith M, McClellan B, Butterworth M. The influence of heredity and environment on human immunoglobulin levels. J Immunol 1969; 102:1504-10.
20. Klaff MW, Hijmans W. Serum immunoglobulin levels in twins. Clin Exp Immunol 1969;5:469-77.
21. Kohler PF, Rivera VJ, Eckert ED, Bouchard TJ, Heston LL. Genetic regulation of immunoglobulin and specific antibody levels in twins reared apart. J Clin Invest 1985;75:883-88.
22. Dunlap NE, Ballinger S, Reed T, Christian JC, Koopman WJ, Briles DE. The use of monozygotic and dizygotic twins to estimate the effects of inheritance on the levels of immunoglobulin isotypes and antibodies to Phosphocholine. Clin Immunol Immunopathol 1993;66: 176-80.
23. Konradsen HB, Henrichsen J, Wachmann H, Holm N, The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins. Clin Exp Immunol 1993;92:532-36.
24. Borecki IB, McGue M, Gerrard JW, Lebowitz MD, Rao DC. Familial resemblance for immunoglobulin levels. Hum Genet 1994;94:179-85.
25. Osoba D, Dick HM, Voller A et al. Role of the HLA complex in the antibody response to malaria under natural conditions. Immunogenetics 1979;8:323-38.
26. Patarroyo ME, Vinasco J, Amador R et al. Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum. Parasite Immunol 1991;13:509-16.
27. Dieye A, Heidrich H-G, Rogier C et al. Lymphocyte response in vitro to Plasmodium falciparum merozoite antigens in donors from a holoendemic area. Parasitol Res 1993;79:629-33.
28. Beck H-P, Felger I, Barker M et al. Evidence of HLA class II associations with antibody response against the malaria vaccine SPf66 in a naturally exposed population. Am J Trop Med Hyg 1995;53:284-88.
29. Sjöberg K, Lepers JP, Raharimalala L et al. Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci USA 1992;89:2101-04.
30. Jepson A, Banya W, Sisay-Joof F et al. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infect Immun 1997;65:872-76.
31. Troye-Blomberg M, Fogdell A, el-Ghazali G et al. Analysis of the T-cell receptor V beta usage in monozygotic and dizygotic twins living in a Plasmodium falciparum endemic area in west Africa. Scand J Immunol 1997;45:541-45.
32. Stirnadel HA, Beck H-P, Alpers MP, Smith TA. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea. Genet Epidemiol 1999;17:16-34.
33. Taylor RR, Egan A, McGuinness D et al. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol 1996;8:905-15.
34. Alpers MP, Al-Yaman F, Beck HP et al. The Malaria Vaccine Epidemiology and Evaluation Project of Papua New Guinea: rationale and baseline studies. P N G Med J 1992;35:285-97.
35. Genton B, Al-Yaman F, Beck H-P et al. The epidemiology of malaria in the Wosera area, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Para 1995;89:359-76.
36. Genton B, Al-Yaman F, Beck H-P et al. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann Trop Med Parasitol 1995;89:377-90.
37. Hui GS, Chang SP, Gibson H et al. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. J Immunol 1991;147:3935-41.
38. Chang SP, Gibson HL, Lee-Ng CT, Barr PJ, Hui GS. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol 1992;149:548-55.
39. Al-Yaman F, Genton B, Taraika J, Alpers MP. Naturally acquired cellular immune responses to the synthetic malarial peptide SPf66 in children in Papua New Guinea. Trans R Soc Trop Med Hyg 1997;91:709-12.
40. Blom G. Statistical Estimates and Transformed Beta Variables. New York: John Wiley & Sons, 1958.
41. Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER, and dGENE [letter]. Genet Epidemiol 1988;5:471-72.
42. Weiss KM. Genetic Variation and Human Disease. Cambridge: Cambridge University Press, 1993.
43. Khoury MJ, Beaty TH, Bernice HC. Fundamentals of Genetic Epidemiology. Oxford: Oxford University Press, 1993.
44. Hopper JL, Mathews JD. A multivariate normal model for pedigree and longitudinal data and the software 'FISHER'. Aust J Stat 1994;36:153-76.
45. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control 1974;19:716-23.
46. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1994.
47. SAGE. Statistical Analysis for Genetic Epidemiology, Release 3.1. Computer program package available from the Department cf Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland. 1998.
48. Zar JH. Biostatistical Analysis. New Jersey: Prentice Hall, 1900.
49. Hviid L, Theander TG. Seasonal changes in human immune responses to malaria. Parasitol Today 1993;9:26-27.
50. Bjorkman A, Perlmann H, Petersen E et al. Consecutive determinations of seroreactivities to Pf 155/RESA antigen and to its different repetitive sequences in adult men from a holoendemic area of Liberia. Parasite Immunol 1990;12:115-23.
51. Troye-Blomberg M, Olerup O, Larsson A et al. Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the Plasmodium falciparum antigen Pf155/RESA. Int Immunol 1991;3:1043-51.
52. Riley EM, Olerup O, Troye-Blomberg M. The immune recognition of malaria antigens. Parasitol Today 1991;7:5-11.
53. Migot F, Chougnet C, Perichon B et al. Lack of correlation between HLA class II alleles and immune responses to Pf155/ring-infected erythrocyte surface antigen (RESA) from Plasmodium falciparum in Madagaskar. Am J Trop Med Hyg 1995;52:252-57.